Classification: Pharmaceutical
Cas NO.: 540737-29-9
Molecular Formula: C16H20N6O.C6H8O7
Tofacitinib (INN) is a drug of the janus kinase (JAK) inhibitor class, discovered and developed by the National Institutes of Health and Pfizer. Tofacitinib citrate is marketed as Xeljanz and Jakvinus.